A large and apprently artificial collection of diverse kinetoplastid protein kinases. A subfamily has 2TM regions, but the majority is cytoplasmic.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 2 |
Pissara et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 24 |
NetGPI | no | yes: 0, no: 24 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005634 | nucleus | 5 | 2 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0016592 | mediator complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: Q4QAI6
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 25 |
GO:0006793 | phosphorus metabolic process | 3 | 25 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 25 |
GO:0006807 | nitrogen compound metabolic process | 2 | 25 |
GO:0007165 | signal transduction | 2 | 3 |
GO:0008152 | metabolic process | 1 | 25 |
GO:0009987 | cellular process | 1 | 25 |
GO:0016310 | phosphorylation | 5 | 25 |
GO:0019538 | protein metabolic process | 3 | 25 |
GO:0036211 | protein modification process | 4 | 25 |
GO:0043170 | macromolecule metabolic process | 3 | 25 |
GO:0043412 | macromolecule modification | 4 | 25 |
GO:0044237 | cellular metabolic process | 2 | 25 |
GO:0044238 | primary metabolic process | 2 | 25 |
GO:0050789 | regulation of biological process | 2 | 3 |
GO:0050794 | regulation of cellular process | 3 | 3 |
GO:0065007 | biological regulation | 1 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 25 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 25 |
GO:0035556 | intracellular signal transduction | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 25 |
GO:0003824 | catalytic activity | 1 | 25 |
GO:0004672 | protein kinase activity | 3 | 25 |
GO:0005488 | binding | 1 | 25 |
GO:0005524 | ATP binding | 5 | 25 |
GO:0016301 | kinase activity | 4 | 25 |
GO:0016740 | transferase activity | 2 | 25 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 25 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 25 |
GO:0017076 | purine nucleotide binding | 4 | 25 |
GO:0030554 | adenyl nucleotide binding | 5 | 25 |
GO:0032553 | ribonucleotide binding | 3 | 25 |
GO:0032555 | purine ribonucleotide binding | 4 | 25 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 25 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 25 |
GO:0036094 | small molecule binding | 2 | 25 |
GO:0043167 | ion binding | 2 | 25 |
GO:0043168 | anion binding | 3 | 25 |
GO:0097159 | organic cyclic compound binding | 2 | 25 |
GO:0097367 | carbohydrate derivative binding | 2 | 25 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 25 |
GO:1901265 | nucleoside phosphate binding | 3 | 25 |
GO:1901363 | heterocyclic compound binding | 2 | 25 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 8 |
GO:0004707 | MAP kinase activity | 5 | 1 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 5 | 1 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 5 | 1 |
GO:0097472 | cyclin-dependent protein kinase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 146 | 150 | PF00656 | 0.507 |
CLV_C14_Caspase3-7 | 503 | 507 | PF00656 | 0.268 |
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.550 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.544 |
CLV_NRD_NRD_1 | 238 | 240 | PF00675 | 0.632 |
CLV_NRD_NRD_1 | 322 | 324 | PF00675 | 0.392 |
CLV_NRD_NRD_1 | 356 | 358 | PF00675 | 0.273 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.633 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 481 | 483 | PF00675 | 0.309 |
CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.584 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.552 |
CLV_PCSK_KEX2_1 | 238 | 240 | PF00082 | 0.634 |
CLV_PCSK_KEX2_1 | 37 | 39 | PF00082 | 0.584 |
CLV_PCSK_KEX2_1 | 481 | 483 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 583 | 585 | PF00082 | 0.364 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.546 |
CLV_PCSK_PC1ET2_1 | 131 | 133 | PF00082 | 0.584 |
CLV_PCSK_PC1ET2_1 | 583 | 585 | PF00082 | 0.341 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.546 |
CLV_PCSK_PC7_1 | 33 | 39 | PF00082 | 0.377 |
CLV_PCSK_PC7_1 | 579 | 585 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.519 |
CLV_PCSK_SKI1_1 | 419 | 423 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 451 | 455 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 481 | 485 | PF00082 | 0.303 |
DEG_SPOP_SBC_1 | 193 | 197 | PF00917 | 0.556 |
DOC_CKS1_1 | 127 | 132 | PF01111 | 0.600 |
DOC_CKS1_1 | 494 | 499 | PF01111 | 0.336 |
DOC_CYCLIN_RxL_1 | 80 | 92 | PF00134 | 0.503 |
DOC_MAPK_DCC_7 | 80 | 88 | PF00069 | 0.505 |
DOC_MAPK_gen_1 | 451 | 460 | PF00069 | 0.313 |
DOC_PP1_RVXF_1 | 389 | 396 | PF00149 | 0.260 |
DOC_PP1_RVXF_1 | 471 | 478 | PF00149 | 0.319 |
DOC_PP4_FxxP_1 | 118 | 121 | PF00568 | 0.583 |
DOC_USP7_MATH_1 | 180 | 184 | PF00917 | 0.626 |
DOC_USP7_MATH_1 | 268 | 272 | PF00917 | 0.569 |
DOC_USP7_MATH_1 | 281 | 285 | PF00917 | 0.484 |
DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.269 |
DOC_USP7_MATH_1 | 467 | 471 | PF00917 | 0.313 |
DOC_USP7_MATH_1 | 62 | 66 | PF00917 | 0.582 |
DOC_USP7_MATH_2 | 121 | 127 | PF00917 | 0.557 |
DOC_USP7_UBL2_3 | 50 | 54 | PF12436 | 0.533 |
DOC_USP7_UBL2_3 | 90 | 94 | PF12436 | 0.531 |
DOC_WW_Pin1_4 | 109 | 114 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 126 | 131 | PF00397 | 0.683 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.522 |
DOC_WW_Pin1_4 | 257 | 262 | PF00397 | 0.544 |
DOC_WW_Pin1_4 | 299 | 304 | PF00397 | 0.465 |
DOC_WW_Pin1_4 | 493 | 498 | PF00397 | 0.351 |
DOC_WW_Pin1_4 | 563 | 568 | PF00397 | 0.298 |
LIG_14-3-3_CanoR_1 | 132 | 137 | PF00244 | 0.563 |
LIG_14-3-3_CanoR_1 | 225 | 231 | PF00244 | 0.547 |
LIG_14-3-3_CanoR_1 | 385 | 391 | PF00244 | 0.270 |
LIG_14-3-3_CanoR_1 | 430 | 437 | PF00244 | 0.276 |
LIG_APCC_ABBA_1 | 402 | 407 | PF00400 | 0.281 |
LIG_BIR_III_4 | 506 | 510 | PF00653 | 0.266 |
LIG_BRCT_BRCA1_1 | 26 | 30 | PF00533 | 0.399 |
LIG_EVH1_2 | 226 | 230 | PF00568 | 0.538 |
LIG_FHA_1 | 193 | 199 | PF00498 | 0.530 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.570 |
LIG_FHA_1 | 431 | 437 | PF00498 | 0.288 |
LIG_FHA_1 | 482 | 488 | PF00498 | 0.409 |
LIG_FHA_2 | 151 | 157 | PF00498 | 0.492 |
LIG_FHA_2 | 460 | 466 | PF00498 | 0.346 |
LIG_FHA_2 | 524 | 530 | PF00498 | 0.297 |
LIG_LIR_Apic_2 | 117 | 121 | PF02991 | 0.583 |
LIG_LIR_Apic_2 | 496 | 502 | PF02991 | 0.330 |
LIG_LIR_Gen_1 | 296 | 306 | PF02991 | 0.449 |
LIG_LIR_Gen_1 | 343 | 354 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 296 | 301 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 332 | 336 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 343 | 349 | PF02991 | 0.396 |
LIG_LIR_Nem_3 | 389 | 393 | PF02991 | 0.367 |
LIG_MYND_1 | 218 | 222 | PF01753 | 0.530 |
LIG_SH2_CRK | 333 | 337 | PF00017 | 0.375 |
LIG_SH2_SRC | 442 | 445 | PF00017 | 0.269 |
LIG_SH2_STAP1 | 295 | 299 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 514 | 518 | PF00017 | 0.372 |
LIG_SH2_STAT5 | 295 | 298 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 337 | 340 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 394 | 397 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 408 | 411 | PF00017 | 0.332 |
LIG_SH2_STAT5 | 442 | 445 | PF00017 | 0.345 |
LIG_SH3_1 | 420 | 426 | PF00018 | 0.290 |
LIG_SH3_2 | 535 | 540 | PF14604 | 0.269 |
LIG_SH3_3 | 100 | 106 | PF00018 | 0.560 |
LIG_SH3_3 | 215 | 221 | PF00018 | 0.570 |
LIG_SH3_3 | 259 | 265 | PF00018 | 0.593 |
LIG_SH3_3 | 420 | 426 | PF00018 | 0.323 |
LIG_SH3_3 | 532 | 538 | PF00018 | 0.272 |
LIG_SH3_3 | 55 | 61 | PF00018 | 0.538 |
LIG_SH3_3 | 68 | 74 | PF00018 | 0.520 |
LIG_SH3_4 | 50 | 57 | PF00018 | 0.528 |
LIG_SUMO_SIM_anti_2 | 233 | 238 | PF11976 | 0.528 |
LIG_SUMO_SIM_par_1 | 368 | 373 | PF11976 | 0.277 |
LIG_SUMO_SIM_par_1 | 546 | 552 | PF11976 | 0.206 |
LIG_SUMO_SIM_par_1 | 84 | 89 | PF11976 | 0.496 |
LIG_TRAF2_1 | 197 | 200 | PF00917 | 0.542 |
LIG_TRAF2_1 | 288 | 291 | PF00917 | 0.483 |
LIG_TRAF2_1 | 561 | 564 | PF00917 | 0.300 |
LIG_WRC_WIRS_1 | 387 | 392 | PF05994 | 0.269 |
MOD_CDK_SPK_2 | 126 | 131 | PF00069 | 0.591 |
MOD_CDK_SPxK_1 | 126 | 132 | PF00069 | 0.587 |
MOD_CDK_SPxxK_3 | 126 | 133 | PF00069 | 0.565 |
MOD_CK1_1 | 122 | 128 | PF00069 | 0.600 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.552 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.533 |
MOD_CK1_1 | 256 | 262 | PF00069 | 0.574 |
MOD_CK1_1 | 314 | 320 | PF00069 | 0.409 |
MOD_CK1_1 | 488 | 494 | PF00069 | 0.269 |
MOD_CK1_1 | 512 | 518 | PF00069 | 0.288 |
MOD_CK2_1 | 111 | 117 | PF00069 | 0.578 |
MOD_CK2_1 | 194 | 200 | PF00069 | 0.585 |
MOD_CK2_1 | 285 | 291 | PF00069 | 0.501 |
MOD_CK2_1 | 523 | 529 | PF00069 | 0.286 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.514 |
MOD_GlcNHglycan | 145 | 148 | PF01048 | 0.576 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.400 |
MOD_GlcNHglycan | 287 | 290 | PF01048 | 0.472 |
MOD_GlcNHglycan | 398 | 401 | PF01048 | 0.424 |
MOD_GlcNHglycan | 414 | 417 | PF01048 | 0.300 |
MOD_GlcNHglycan | 437 | 440 | PF01048 | 0.350 |
MOD_GlcNHglycan | 506 | 510 | PF01048 | 0.300 |
MOD_GlcNHglycan | 511 | 514 | PF01048 | 0.302 |
MOD_GlcNHglycan | 541 | 544 | PF01048 | 0.309 |
MOD_GlcNHglycan | 551 | 554 | PF01048 | 0.315 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.649 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.562 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.547 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.559 |
MOD_GSK3_1 | 172 | 179 | PF00069 | 0.541 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.587 |
MOD_GSK3_1 | 253 | 260 | PF00069 | 0.531 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.630 |
MOD_GSK3_1 | 293 | 300 | PF00069 | 0.435 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.379 |
MOD_GSK3_1 | 394 | 401 | PF00069 | 0.212 |
MOD_GSK3_1 | 424 | 431 | PF00069 | 0.242 |
MOD_GSK3_1 | 481 | 488 | PF00069 | 0.329 |
MOD_GSK3_1 | 489 | 496 | PF00069 | 0.387 |
MOD_GSK3_1 | 505 | 512 | PF00069 | 0.299 |
MOD_GSK3_1 | 519 | 526 | PF00069 | 0.449 |
MOD_GSK3_1 | 551 | 558 | PF00069 | 0.342 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.567 |
MOD_N-GLC_1 | 314 | 319 | PF02516 | 0.365 |
MOD_N-GLC_2 | 386 | 388 | PF02516 | 0.269 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.552 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.367 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.544 |
MOD_NEK2_1 | 310 | 315 | PF00069 | 0.395 |
MOD_NEK2_1 | 459 | 464 | PF00069 | 0.320 |
MOD_NEK2_1 | 549 | 554 | PF00069 | 0.365 |
MOD_NEK2_2 | 281 | 286 | PF00069 | 0.502 |
MOD_NEK2_2 | 342 | 347 | PF00069 | 0.269 |
MOD_PIKK_1 | 430 | 436 | PF00454 | 0.337 |
MOD_PIKK_1 | 442 | 448 | PF00454 | 0.229 |
MOD_PIKK_1 | 465 | 471 | PF00454 | 0.320 |
MOD_PIKK_1 | 485 | 491 | PF00454 | 0.392 |
MOD_PKA_1 | 132 | 138 | PF00069 | 0.544 |
MOD_PKA_1 | 481 | 487 | PF00069 | 0.269 |
MOD_PKA_1 | 583 | 589 | PF00069 | 0.335 |
MOD_PKA_1 | 94 | 100 | PF00069 | 0.552 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.561 |
MOD_PKA_2 | 164 | 170 | PF00069 | 0.627 |
MOD_PKA_2 | 285 | 291 | PF00069 | 0.549 |
MOD_PKA_2 | 329 | 335 | PF00069 | 0.284 |
MOD_PKA_2 | 481 | 487 | PF00069 | 0.336 |
MOD_PKA_2 | 583 | 589 | PF00069 | 0.326 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.565 |
MOD_Plk_1 | 122 | 128 | PF00069 | 0.565 |
MOD_Plk_1 | 148 | 154 | PF00069 | 0.511 |
MOD_Plk_1 | 212 | 218 | PF00069 | 0.562 |
MOD_Plk_4 | 332 | 338 | PF00069 | 0.392 |
MOD_Plk_4 | 424 | 430 | PF00069 | 0.284 |
MOD_Plk_4 | 489 | 495 | PF00069 | 0.269 |
MOD_Plk_4 | 53 | 59 | PF00069 | 0.535 |
MOD_ProDKin_1 | 109 | 115 | PF00069 | 0.550 |
MOD_ProDKin_1 | 126 | 132 | PF00069 | 0.683 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.523 |
MOD_ProDKin_1 | 257 | 263 | PF00069 | 0.545 |
MOD_ProDKin_1 | 299 | 305 | PF00069 | 0.463 |
MOD_ProDKin_1 | 493 | 499 | PF00069 | 0.351 |
MOD_ProDKin_1 | 563 | 569 | PF00069 | 0.298 |
MOD_SUMO_rev_2 | 87 | 97 | PF00179 | 0.508 |
TRG_ENDOCYTIC_2 | 333 | 336 | PF00928 | 0.375 |
TRG_ENDOCYTIC_2 | 337 | 340 | PF00928 | 0.375 |
TRG_ER_diArg_1 | 160 | 162 | PF00400 | 0.553 |
TRG_ER_diArg_1 | 214 | 217 | PF00400 | 0.558 |
TRG_ER_diArg_1 | 237 | 239 | PF00400 | 0.578 |
TRG_ER_diArg_1 | 36 | 38 | PF00400 | 0.347 |
TRG_ER_diArg_1 | 382 | 385 | PF00400 | 0.272 |
TRG_ER_diArg_1 | 481 | 483 | PF00400 | 0.334 |
TRG_NES_CRM1_1 | 362 | 375 | PF08389 | 0.298 |
TRG_NLS_Bipartite_1 | 37 | 53 | PF00514 | 0.489 |
TRG_NLS_MonoCore_2 | 48 | 53 | PF00514 | 0.524 |
TRG_NLS_MonoExtC_3 | 418 | 423 | PF00514 | 0.269 |
TRG_NLS_MonoExtC_3 | 48 | 53 | PF00514 | 0.524 |
TRG_NLS_MonoExtN_4 | 130 | 135 | PF00514 | 0.550 |
TRG_Pf-PMV_PEXEL_1 | 481 | 485 | PF00026 | 0.275 |
TRG_Pf-PMV_PEXEL_1 | 84 | 89 | PF00026 | 0.496 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTF0 | Leptomonas seymouri | 59% | 95% |
A0A0S4JKJ7 | Bodo saltans | 26% | 91% |
A0A3Q8ICW9 | Leishmania donovani | 92% | 100% |
A0A3Q8ITZ9 | Leishmania donovani | 25% | 100% |
A0A3S5H5G0 | Leishmania donovani | 26% | 100% |
A0A3S7WRG1 | Leishmania donovani | 24% | 100% |
A4H459 | Leishmania braziliensis | 26% | 100% |
A4H601 | Leishmania braziliensis | 22% | 100% |
A4H9U7 | Leishmania braziliensis | 22% | 100% |
A4HDJ5 | Leishmania braziliensis | 79% | 100% |
A4HFA1 | Leishmania braziliensis | 26% | 100% |
A4HLJ9 | Leishmania braziliensis | 24% | 100% |
A4HSE2 | Leishmania infantum | 26% | 100% |
A4HUS3 | Leishmania infantum | 24% | 100% |
A4I0Y4 | Leishmania infantum | 92% | 100% |
A4I910 | Leishmania infantum | 25% | 100% |
E8NHK0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9ANF7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AWZ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
E9B3X5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
Q4Q449 | Leishmania major | 25% | 100% |
Q4QH69 | Leishmania major | 24% | 100% |
Q4QJJ0 | Leishmania major | 26% | 100% |